HomeRSPI • OTCMKTS
add
Respirerx Pharmaceuticals Inc
Previous close
$0.0020
Year range
$0.00020 - $0.0069
Market cap
730.84K USD
Avg Volume
397.00K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 332.51K | -14.51% |
Net income | -395.50K | 16.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.36K | 10,503.33% |
Total assets | 108.66K | 114.74% |
Total liabilities | 12.41M | 6.56% |
Total equity | -12.30M | — |
Shares outstanding | 365.42M | — |
Price to book | -0.05 | — |
Return on assets | -665.18% | — |
Return on capital | 8.85% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -395.50K | 16.31% |
Cash from operations | -100.96K | -44.35% |
Cash from investing | — | — |
Cash from financing | 100.00K | 42.90% |
Net change in cash | -959.00 | -2,558.97% |
Free cash flow | -153.07K | -257.80% |
About
RespireRx Pharmaceuticals Inc. is a pharmaceutical company based in Glen Rock, New Jersey specializing in positive allosteric modulators of the AMPA receptor known as Ampakines. Wikipedia
Founded
1987
Headquarters
Website
Employees
2
